[1] Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol. 2020;92(4):401-402.
[2] Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O.et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264-266.
[3] Paules CI, Marston HD, Fauci AS. Coronavirus Infections-More Than Just the Common Cold. JAMA. 2020;323(8):707-708.
[4] Wuhan Municipal Health Commission. Report of novel coronavirus-infected pneumonia in China. Jan20, 2020.
[5] Phan LT, Nguyen TV, Luong QC, Nguyen TV, Nguyen HT, Le HQ, et al. Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam. N Engl J Med. 2020;382(9):872-874.
[6] Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514-523.
[7] Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y. et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020 Jan 29. doi: 10.1056/NEJMoa2001316. [Epub ahead of print]. https://www.nejm.org/doi/full/10.1056/NEJMoa2001316
[8] Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med. 2020. [Epub ahead of print]. https://www.nejm.org/doi/full/10.1056/NEJMc2001468
[9] Wu JT, Leung K, Leung GM. Now casting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: A modeling study. Lancet. 2020. [Epub ahead of print]. https://doi.org/10.1016/S0140-6736(20)30260-9
[10] WHO main website. https://www.who.int (accessed February 5th, 2020)
[11] WHO main website. https://www.who.int (accessed March 2th, 2020)
[12] Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl). 2020Feb7. [Epub ahead of print]. https://journals.lww.com/cmj/Abstract/publishahead/Clinical_characteristics_of_novel_coronavirus.99408.aspx
[13] Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513
[14] Arabi YM, Fowler R, Hayden FG. Critical care management of adults with community-acquired severe respiratory viral infection. Intensive Care Med. 2020 Feb;46(2):315-328.
[15] Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z, et al. Characteristics of COVID-19 infection in Beijing. J Infect 2020 Feb 26. [Epub ahead of print] https://www.sciencedirect.com/science/article/pii/S0163445320301018
[16] COVID-19 National Incident Room Surveillance Team. COVID-19, Australia: Epidemiology Report 2.2020
[17] National Health Commission of China. Diagnosis and Treatment of Novel Coronavirus Pneumonia (5th edition) 2020.
[18] Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012 Sep;65(9):934-9.
[19] WHO. Statement on the meeting of the International Health Regulations(2005) Emergency Committee regarding the outbreak of novel coronavirus(2019-nCoV). posting date. 2020.
[20] Shen M, Peng Z, Xiao Y, Zhang L. Modelling the epidemic trend of the 2019novel coronavirus outbreak in China. bioRxiv. 2020 Jan25. [Epub ahead of print] Available from: https://www.biorxiv.org/content/10.1101/2020.01.23.916726v1
[21] Chen J. Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses. Microbes Infect. 2020 Feb 4. [Epub ahead of print]. Available from: https://www.sciencedirect.com/science/article/pii/S1286457920300265
[22] Jiang S, Du L, Shi Z. An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies. Emerg Microb Infect. 2020Dec;9(1):275-277.
[23] Rodriguez-Morales, A.J., Cardona-Ospina, J.A., Gutiérrez-Ocampo, E., Villamizar-Peña, R., Holguin-Rivera, Y., Escalera-Antezana, J.P. et al. Clinical, Laboratory and Imaging Features of COVID-19: A Systematic Review and Meta-analysis. medicine & pharmacology. 2020Feb.[Epub ahead of print]. https://www.preprints.org/manuscript/202002.0378/v1
[24] Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 Feb 24. [Epub ahead of print]. https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30079-5/fulltext
[25] Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Feb 7. [Epub ahead of print]. https://jamanetwork.com/journals/jama/fullarticle/2761044
[26] Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506
[27] Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020, 395(10223):473-475.
[28] Yan L, Li YS. Identification and treatment strategies for patients with COVID-19. Journal of New Medicine. 2020. [Epub ahead of print]. http://kns.cnki.net/kcms/detail/44.1211.r.20200227.1819.004.html
[29] Fang XW, Mei Q, Yang TJ, Zhang Lei, Yang Yun, Wang Yinzhong, et al. Clinical characteristics and treatment strategies of 79 patients with COVID-19. Chinese Pharmacological Bulletin. 2020,36(4):11-18.
[30] Chen M, An W, Xia F, Yang Ping, Liao Yaling et al. Retrospective Analysis of COVID-19 Patientswith Different Clinical Subtypes. Herald of Medicine.2020 Feb 27.[Epub ahead of print]. http://kns.cnki.net/kcms/detail/42.1293.R.20200226.1852.004.html
[31] Chen L, Feng SY, Wang FX, Chen CM, Wu WB, Jiang X. Clinical diagnosis and treatment of critical patients with novel coronavirus pneumonia(report of 12 cases). Chinese journal of Clinical Medicine. 2020,27(1):1-4.
[32] Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Feb 28. [Epub ahead of print]. https://www.nejm.org/doi/full/10.1056/NEJMoa2002032